ETFs ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - NYSE 16:00:02 2026-11-02 EST			5-day change	1st Jan Change
232.94 ^USD	+1.30%		-8.00%	-3.29%

11-02	ResMed Likely Able to Sustain Earnings Growth, UBS Says	MT
10-30	RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating	MT

ETFs positioned on ResMed, Inc.

Name	YTD change	Weight	AuM
SCHWAB U.S. BROAD MARKET ETF - USD	+10.37%	-	44,934 M€
SOUNDWATCH HEDGED EQUITY ETF - USD	+2.61%	-	165 M€
PACER PE/VC ETF - USD	+2.23%	-	3 M€
UBS MSCI USA SELECT FACTOR MIX UCITS ETF (HEDGED TO CHF) A-ACC - CHF	+10.28%	-	28 M€
UBS MSCI WORLD EX USA CLIMATE PARIS ALIGNED UCITS ETF A-ACC - USD	+11.90%	-	66 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+9.48%	-	67 M€
MOTLEY FOOL CAPITAL EFFICIENCY 100 INDEX ETF - USD	+3.97%	-	80 M€
VANGUARD S&P 500 UCITS ETF - ACC - USD	+15.67%	-	35,761 M€
UBS MSCI ACWI CLIMATE PARIS ALIGNED UCITS ETF ACC - USD	+11.20%	-	122 M€
STATE STREET SPDR S&P WORLD EX AUSTRALIA CARBON AWARE (HEDGED) ETF - AUD	+0.53%	-	293 M€
BNP PARIBAS EASY S&P 500 SCORED AND SCREENED UCITS ETF - EUR	+16.03%	-	669 M€
HSBC MSCI WORLD UCITS ETF (C) - USD	+15.20%	-	2,303 M€
FIRST TRUST NASDAQ LUX DIGITAL HEALTH SOLUTIONS ETF - USD	+23.51%	8.02%	4 M€
ISHARES U.S. MEDICAL DEVICES ETF - USD	-9.07%	4.61%	3,478 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH ETF - USD	+5.19%	4.61%	31 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF - USD	+19.86%	4.23%	6 M€
GLOBAL X TELEMEDICINE & DIGITAL HEALTH UCITS ETF DIST - USD	+19.10%	3.99%	0 M€
ISHARES US MEDICAL DEVICES UCITS ETF (ACC) - USD	-11.10%	2.83%	234 M€
FT VEST GROWTH STRENGTH & TARGET INCOME ETF - USD	-0.60%	1.89%	2 M€
FIRST TRUST GROWTH STRENGTH ETF - USD	+6.42%	1.87%	1,356 M€
FIRST TRUST CAPITAL STRENGTH UCITS ETF - USD	+11.70%	1.8%	9 M€
STATE STREET SPDR S&P HEALTH CARE EQUIPMENT ETF - USD	+4.99%	1.77%	176 M€
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF - USD	+8.82%	1.69%	8 M€
INVESCO S&P 500 EQUAL WEIGHT HEALTH CARE ETF - USD	+25.27%	1.64%	792 M€
WBI BULLBEAR QUALITY 3000 ETF - USD	+11.53%	1.52%	31 M€
VANECK MORNINGSTAR SMID MOAT ETF - USD	+13.73%	1.25%	335 M€
BMO EQUAL WEIGHT U.S. HEALTH CARE INDEX ETF - CAD HEDGED	+18.22%	1.2%	131 M€

1 2 3 4 5

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.

Employees

11,370

Sector

Advanced Medical Equipment & Technology

Calendar

11-12 Ex-dividend date - 0.66 USD

More about the company